Cancer Screening 3 Years After the Onset of the COVID-19 Pandemic
JAMA · 06.05.2025 · 333 (17) · 1543
DOI: 10.1001/jama.2025.0902 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, erschienen am 06.05.2025. Verfasst von Jessica Star und 5 weiteren Autor:innen. Beteiligte Einrichtung: Surveillance and Health Equity Science, American Cancer Society, Atlanta, Georgia. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
This study examines post–COVID-19 pandemic cancer screening rates in 2023 relative to previously documented declines through 2021.
Autor:innen und Institutionen
- Surveillance and Health Equity Science, American Cancer Society, Atlanta, Georgia.
- Early Cancer Detection Science, American Cancer Society, Atlanta, Georgia.
Zitieren
APA
Star, J., Han, X., Smith, R. A., Schafer, E. J., Jemal, A., & Bandi, P. (2025). Cancer Screening 3 Years After the Onset of the COVID-19 Pandemic. JAMA, 333(17), 1543. https://doi.org/10.1001/jama.2025.0902
Vancouver
Star J, Han X, Smith RA, Schafer EJ, Jemal A, Bandi P. Cancer Screening 3 Years After the Onset of the COVID-19 Pandemic. JAMA. 2025;333(17):1543. doi:10.1001/jama.2025.0902
BibTeX
@article{Star2025,
author = {Star, Jessica and Han, Xuesong and Smith, Robert A and Schafer, Elizabeth J and Jemal, Ahmedin and Bandi, Priti},
title = {Cancer Screening 3 Years After the Onset of the COVID-19 Pandemic},
journal = {JAMA},
year = {2025},
volume = {333},
number = {17},
pages = {1543},
doi = {10.1001/jama.2025.0902}
}
EUVIMED